Management of mantle cell lymphoma in the elderly patient - sprookjes - yvandenbroek - TriplyDB

Management of mantle cell lymphoma in the elderly patient

Management of mantle cell lymphoma in the elderly patient

http://www.wikidata.org/entity/Q26999395

about

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents Primary bone mantle cell lymphomas with multiple vertebral compression fractures: A case report.

P2860

Q28075606-CFD6D5E4-A36A-4D54-B0CC-CD504782E806 Q39270314-18A4CADB-DFC9-4C80-AA87-45FECE9CD24D

P2860

Management of mantle cell lymphoma in the elderly patient

http://www.wikidata.org/entity/Q26999395

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Management of mantle cell lymphoma in the elderly patient

@ast

Management of mantle cell lymphoma in the elderly patient

@en

Management of mantle cell lymphoma in the elderly patient

@nl

type

label

Management of mantle cell lymphoma in the elderly patient

@ast

Management of mantle cell lymphoma in the elderly patient

@en

Management of mantle cell lymphoma in the elderly patient

@nl

prefLabel

Management of mantle cell lymphoma in the elderly patient

@ast

Management of mantle cell lymphoma in the elderly patient

@en

Management of mantle cell lymphoma in the elderly patient

@nl

P1433

Q26999395-1A34A85C-835D-4C95-B755-7F4E07DE5EC5

P1476

Q26999395-2283D694-25BF-4094-ADDD-65B928F22796

P2093

Q26999395-FB87A78B-74AE-47F9-9417-CCFC93EDBC11

P275

Q26999395-2F1EF79E-326D-4ABE-95C7-616EC4225D00

P2860

Q26999395-063504D4-D340-4C6A-B32E-DC2242681CCF

Q26999395-0DF6D00B-98DE-420C-8A33-F0599AE1EF37

Q26999395-0ED48E34-D516-4D3A-822F-5A3FA244BC9E

Q26999395-12F5CD46-CCDE-490D-B84D-61A6AA34FE57

Q26999395-1397B273-D52D-45B3-A490-5A39976C0B26

Q26999395-197A3B77-EBC3-4627-97B7-29927785762E

Q26999395-1A0C0DE6-CD31-4367-903A-47BF119A40A0

Q26999395-1CA1669C-B2B6-46B2-9CFD-2633A79131DA

Q26999395-20C7D7B7-DB1C-4500-9C23-E17B50BD962D

Q26999395-2B09A3D7-ACC6-41D8-A5E2-72241C66C445

P304

Q26999395-88E9E4F6-6288-4626-AC64-CC3A3B5E8206

P31

Q26999395-DDC0F4D4-9FE2-4C97-8BCA-248722BFB3B7

P3181

Q26999395-3C3F0C7E-F302-49F1-85BB-0E2AC65E3040

P356

Q26999395-40C8CAF0-1FE3-4165-82F4-C0764C906285

P407

Q26999395-B4A59A60-71C7-4674-8816-42D3A20EBBF2

P478

Q26999395-4CA44B4F-C6A3-47FB-8DAD-02956C9DA68F

P50

Q26999395-B8C7E8D3-DD7A-4347-8790-96F35404AA99

P5008

Q26999395-92386D8E-2249-43FE-A2D3-C060CC39AA81

P577

Q26999395-B7275803-E16B-4A9F-A083-BCAF4AFADC6E

P698

Q26999395-AA759155-2240-4800-B6B2-2F01FC20CB99

P921

Q26999395-C11D5BE8-8200-439A-AD1B-AFA89DF27F03

Q26999395-C50D8B39-3943-49E8-8B69-25A70E905299

P932

Q26999395-3084CFE6-5A44-4848-B228-2EAE7A1CAA4F

P3181

P356

P1433

Clinical Interventions in Aging

P1476

Management of mantle cell lymphoma in the elderly patient

@en

P2093

Jeanette K Doorduijn

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Limited-stage mantle-cell lymphoma

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

Report of the Committee on Hodgkin's Disease Staging Classification

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma.

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

P304

1229-1236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4885746

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/CIA.S35082

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Hanneke C Kluin-Nelemans

P5008

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24072968

http://www.w3.org/2001/XMLSchema#string

P921

mantle cell lymphoma

P932

3783516

http://www.w3.org/2001/XMLSchema#string